Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Haematologica
Hlavní autoři: Dimopoulos, Meletios A., Orlowski, Robert Z., Facon, Thierry, Sonneveld, Pieter, Anderson, Kenneth C., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Potamianou, Anna, Couturier, Catherine, Feng, Huaibao, Ataman, Ozlem, van de Velde, Helgi, Richardson, Paul G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2015
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281322/
https://ncbi.nlm.nih.gov/pubmed/25261096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112037
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky